FDA Efforts To Curb Flavored Vapes Said To Draw Supreme Court Review
Portfolio Pulse from Benzinga Newsdesk
The FDA's efforts to curb flavored vapes are set to draw a review from the Supreme Court. This regulatory action could impact companies involved in the production and sale of flavored vaping products.
July 02, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Altria Group (MO) could face regulatory challenges as the FDA's efforts to curb flavored vapes draw Supreme Court review.
Altria Group is significantly involved in the vaping market, and regulatory actions against flavored vapes could negatively impact its business.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Philip Morris International (PM) might be affected by the FDA's regulatory actions on flavored vapes, pending Supreme Court review.
Philip Morris International has a stake in the vaping market, and regulatory scrutiny on flavored vapes could pose challenges.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
22nd Century Group (XXII) may experience regulatory pressures as the FDA's efforts to curb flavored vapes are reviewed by the Supreme Court.
22nd Century Group, involved in the vaping industry, could be impacted by regulatory actions against flavored vapes.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60